Curiox Biosystems
Seoul
About Curiox Biosystems
Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox’s vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $30.0M
- Funding stage: IPO
- Last round: Series C (Mar 2022)
- Ticker: kosdaq:445680
- Website: curiox.com
- Phone: +82 2 2039 7160
Industries & Categories
Biotechnology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/curiox-biosystems-25615 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.